Io Biotech, Inc.
IOBTCIK 0001865494 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K filed Mar 31, 2025. Sentiment + YoY language diff vs prior year. Read sections →
Signal:Material rewriteFull-doc fallback
Full filing:tone -0.0143Δ-0.00876% similar+1845/-48 ¶
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Io Biotech, Inc.
| Name | Roles | Filings |
|---|---|---|
| Lundbeckfond Invest A/S | Director10% Owner | 1 |
| Vivo Capital Fund IX, L.P. | 10% Owner | 1 |
| Vivo Capital IX, LLC | 10% Owner | 1 |
| Vivo Opportunity Fund Holdings, L.P. | 10% Owner | 1 |
| Vivo Opportunity, LLC | 10% Owner | 1 |
Showing 16-20 of 20
PrevPage 4 of 4
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Io Biotech, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Novo Holdings A/S | 5 | 60% | -6.1% | +3.1% | +7.5% | -45.8% |
All filings
60 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|